RXHN.OB Insider Trading Activity and SEC Form 4 Filings
RXHN.OB insider trading summary
No open-market insider purchases or sales of Rexahn Pharmaceuticals, Inc. (RXHN.OB) have been reported on SEC Form 4 in the past 12 months.
Latest RXHN.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 5, 2008 | Kwang Soo Cheong | Director | Buy | $7K (3,000 @ $2.25) |
| Apr 24, 2008 | Y Michele Kang | Director | Buy | $4K (1,500 @ $2.35) |
| Apr 24, 2008 | Y Michele Kang | Director | Buy | $1K (500 @ $2.35) |
| Apr 23, 2008 | Y Michele Kang | Director | Buy | $2K (1,000 @ $2.30) |
| Apr 23, 2008 | Y Michele Kang | Director | Buy | $2K (1,000 @ $2.35) |
| Apr 23, 2008 | Y Michele Kang | Director | Buy | $2K (1,000 @ $2.35) |
| Apr 23, 2008 | Y Michele Kang | Director | Buy | $6K (2,500 @ $2.30) |
| Apr 23, 2008 | Y Michele Kang | Director | Buy | $2K (1,000 @ $2.35) |
| Apr 23, 2008 | Y Michele Kang | Director | Buy | $1K (500 @ $2.25) |
| Apr 23, 2008 | Y Michele Kang | Director | Buy | $2K (1,000 @ $2.35) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.